Literature DB >> 10163630

Alcoholism. The cost of illness in the Federal Republic of Germany.

J G Brecht1, F Poldrugo, P K Schädlich.   

Abstract

The purpose of this study was to estimate the direct and indirect costs of alcoholism in the Federal Republic of Germany. Direct costs comprised treatment costs, while indirect costs consisted mainly of costs incurred as a result of work time lost, as well as costs related to premature retirement and premature mortality. The costs of alcoholism were estimated using the aggregated statistics of several social security organisations and official statistics. For the purposes of this study, alcoholism was defined as alcohol dependence syndrome [9th revision of the International Classification of Diseases code (ICD) 303], alcoholic chronic liver disease and cirrhosis (ICD 571.0 to 571.3), and alcoholic psychoses (ICD 291). The reference period consisted of the years 1985 to 1991. All statistics and all analyses were limited to the so-called old states of Germany, within the boundaries as they were before 3rd October 1990. The overall monetary burden (in 1990 Deutschemarks) of alcoholism in the western part of Germany in 1990 was estimated to be DM5975 million. Alcoholism is associated with considerably more indirect costs (DM4422 million) than direct costs (DM1553 million). The predominance of indirect costs is mainly the result of the very high premature mortality of patients with alcoholism. Thus, the cost of premature mortality makes up more than half of the indirect costs of alcoholism (DM2284 million), while about a quarter of the indirect costs (DM1150 million) are associated with inability to work. Early retirement accounts for a similar amount (DM988 million). The majority of direct costs is accounted for by treatment in acute hospitals (DM869 million). Costs incurred as a result of rehabilitation treatment (DM373 million) and ambulatory care (DM331 million) are also considerable.

Entities:  

Mesh:

Year:  1996        PMID: 10163630     DOI: 10.2165/00019053-199610050-00006

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  4 in total

1.  The state of the art of cost-of-illness estimates.

Authors:  T A Hodgson
Journal:  Adv Health Econ Health Serv Res       Date:  1983

2.  The economic cost of illness in the Federal Republic of Germany in the year 1980.

Authors:  K D Henke; C S Behrens
Journal:  Health Policy       Date:  1986       Impact factor: 2.980

3.  The reduction of health care costs associated with alcoholism treatment: a 14-year longitudinal study.

Authors:  H D Holder; J O Blose
Journal:  J Stud Alcohol       Date:  1992-07

Review 4.  Mortality studies in the long-term evaluation of treatment of alcoholics.

Authors:  F Poldrugo; J D Chick; N Moore; J A Walburg
Journal:  Alcohol Alcohol Suppl       Date:  1993
  4 in total
  8 in total

1.  Association of alcohol consumption to mortality and person-years of life lost in Switzerland--measuring the impact of some methodological options.

Authors:  Elisabeth Gutjahr; Gerhard Gmel
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  Acamprosate. Pharmacoeconomic implications of therapy.

Authors:  R H Foster; K J McClellan
Journal:  Pharmacoeconomics       Date:  1999-12       Impact factor: 4.981

3.  The cost effectiveness of acamprosate in the treatment of alcoholism in Germany. Economic evaluation of the Prevention of Relapse with Acamprosate in the Management of Alcoholism (PRAMA) Study.

Authors:  P K Schädlich; J G Brecht
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

4.  Cost of stress urinary incontinence: a claims data analysis.

Authors:  Howard G Birnbaum; Stephanie A Leong; Emily F Oster; Kraig Kinchen; Peter Sun
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

5.  Direct and indirect costs attributable to alcohol consumption in Germany.

Authors:  Alexander Konnopka; Hans-Helmut König
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

6.  Annual cost of hospitalization, inpatient rehabilitation, and sick leave for head and neck cancers in Germany.

Authors:  Jens P Klussmann; Peter K Schädlich; Xiaoyu Chen; Vanessa Rémy
Journal:  Clinicoecon Outcomes Res       Date:  2013-05-16

7.  Acamprosate in the treatment of alcoholism: a budget impact analysis for the National Health Service in Italy.

Authors:  Giorgio L Colombo; Sergio Di Matteo; Giacomo Bruno
Journal:  Subst Abuse Rehabil       Date:  2012-07-17

8.  Economic burden associated with alcohol dependence in a German primary care sample: a bottom-up study.

Authors:  Jakob Manthey; Philippe Laramée; Steve Parrott; Jürgen Rehm
Journal:  BMC Public Health       Date:  2016-08-31       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.